CD4+ T cell affinity for self and foreign antigens in the CNS
CD4 T 细胞对 CNS 中自身和外来抗原的亲和力
基本信息
- 批准号:8668170
- 负责人:
- 金额:$ 32.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdoptive TransferAffinityAgreementAntigensAutoantigensAutoimmune ResponsesAutoimmunityAvidityBiological AssayCD4 Positive T LymphocytesCD8B1 geneCellsChronicChronic DiseaseChronic PhaseClinicalDevelopmentDiseaseDisease OutcomeDisease ProgressionEpitopesExperimental Autoimmune EncephalomyelitisExperimental DesignsFrequenciesGoalsGrantHealthHelper-Inducer T-LymphocyteHistocompatibility Antigens Class IIHumanImmuneImmune responseIn VitroInflammationIonomycinLymphocytic choriomeningitis virusMeasurementMeasuresMediatingMethodsModelingMultiple SclerosisMusMyelinNatureNeuraxisOutcomePathogenesisPathologyPatientsPatternPeptide/MHC ComplexPeptidesPhenotypePlayPopulationPredictive FactorProcessProteinsReagentRegulationRegulatory T-LymphocyteReportingResearchRoleSeveritiesSignal TransductionSiteStagingSymptomsT cell responseT-Cell ActivationT-LymphocyteTechniquesTechnologyTestingTherapeutic InterventionTimeTissuesTreatment EfficacyViralViral AntigensVirus DiseasesWorkbasecell injurychronic autoimmune diseasecytokineeffective therapyexhaustimmune activationimprovedin vivoinnovationneurofilamentnoveloligodendrocyte-myelin glycoproteinoutcome forecastpathogenpreventresearch studyresponsetool
项目摘要
To date, our best tools for assessing the frequency and affinity of CD4+ T cells have been peptide:MHC
(pMHC) tetramers or functional assays; neither of which effectively identify all of the responding cells to a
particular antigen. This is in contrast to CD8+ T cells where these techniques prove more accurate.
Generally, pMHC tetramers for class II antigens are difficult to produce and identify a small percentage of
responding CD4+ T cells especially when antigen is derived from self proteins. The reason for this is that
tetramer is based on affinity and if affinity is too low, then the tetramer is of limited use in assessing the
response Functional responses also underestimate the number of antigen reactive CD4+ T cells. In the case
of responses directed against myelin antigens for instance, the effector cytokine response is often determined
using strong pharmacologic agents such as PMA and ionomycin, which hammer the T cell signaling cascade
and may have little relevance to the cytokines being produced in response to antigen itself. To better assess
the range of responding CD4+ T cells, we have begun to use micropipette based affinity assay. We report
here a major advancement in assessment in the frequency and affinity of CD4+ T cells directed against myelin
or viral antigens. Therefore for the first time, it is possible to track the range of affinities of a CD4+ T cells
response during disease progression. Our preliminary findings have led to the following central hypothesis that
the CD4+ T cell affinity profile directly impacts disease outcome and immune mediated tissue damage in the
CNS. Three specific aims are proposed to test this hypothesis focused on CD4+ T cells specific for self
antigen myelin oligodendrocyte glycoprotein and pathogen associated lymphocytic choriomeningitis virus
antigens.
Aim 1- Identify the affinity of CD4+ T cells over the course of chronic autoimmune disease and viral
infection.
Aim 2- Define the connection between T cell affinity and effector phenotype.
Aim 3- Establish the contribution of high versus low affinity T cells in response to antigens found in
the CNS.
迄今为止,我们评估CD 4 + T细胞频率和亲和力的最佳工具是肽:MHC
(pMHC)四聚体或功能测定;这两种方法都不能有效地鉴定对一种抗原的所有应答细胞。
特殊抗原这与CD 8 + T细胞相反,这些技术证明更准确。
通常,II类抗原的pMHC四聚体难以产生并鉴定小百分比的pMHC四聚体。
应答性CD 4 + T细胞,尤其是当抗原来源于自身蛋白时。其原因是
四聚体是基于亲和力的,如果亲和力太低,那么四聚体在评估生物活性中的用途有限。
功能性应答也低估了抗原反应性CD 4 + T细胞的数量。的情况下
例如,在针对髓鞘抗原的应答中,
使用强力药物,如PMA和离子霉素,打击T细胞信号级联
并且可能与响应抗原本身而产生的细胞因子几乎没有相关性。更好地评估
为了确定应答的CD 4 + T细胞的范围,我们已经开始使用基于微量移液器的亲和力测定。我们报告
这是在评估CD 4 + T细胞对髓磷脂的频率和亲和力方面的一个重大进展,
或病毒抗原。因此,第一次有可能跟踪CD 4 + T细胞的亲和力范围。
疾病进展期间的反应。我们的初步发现导致了以下中心假设,
CD 4 + T细胞亲和力谱直接影响疾病结果和免疫介导的组织损伤,
CNS。提出了三个具体目标来检验这一假设,重点是对自身免疫特异性的CD 4 + T细胞。
抗原髓鞘少突胶质细胞糖蛋白和病原体相关淋巴细胞性脉络丛脑膜炎病毒
抗原
目的1-确定慢性自身免疫性疾病和病毒感染过程中CD 4 + T细胞的亲和力。
感染
目的2-确定T细胞亲和力和效应表型之间的联系。
目的3-确定高亲和力T细胞与低亲和力T细胞在应答中发现的抗原的贡献,
CNS。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian D Evavold其他文献
Brian D Evavold的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian D Evavold', 18)}}的其他基金
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 32.72万 - 项目类别:
Defining how TCR strength of signal modulates Treg function
定义 TCR 信号强度如何调节 Treg 功能
- 批准号:
10707431 - 财政年份:2022
- 资助金额:
$ 32.72万 - 项目类别:
Defining how TCR strength of signal modulates Treg function
定义 TCR 信号强度如何调节 Treg 功能
- 批准号:
10608466 - 财政年份:2022
- 资助金额:
$ 32.72万 - 项目类别:
Biomedical Research Inclusion & Diversity to Grow Excellence in Science - Undergraduate Program in Pathology for HBCUs (BRIDGE-UP HBCU)
生物医学研究包容性
- 批准号:
10487779 - 财政年份:2022
- 资助金额:
$ 32.72万 - 项目类别:
Pathogenic low affinity CD8 T cells in malaria
疟疾中的致病性低亲和力 CD8 T 细胞
- 批准号:
10490915 - 财政年份:2021
- 资助金额:
$ 32.72万 - 项目类别:
Pathogenic low affinity CD8 T cells in malaria
疟疾中的致病性低亲和力 CD8 T 细胞
- 批准号:
10392126 - 财政年份:2021
- 资助金额:
$ 32.72万 - 项目类别:
Pathogenic low affinity CD8 T cells in malaria
疟疾中的致病性低亲和力 CD8 T 细胞
- 批准号:
10676265 - 财政年份:2021
- 资助金额:
$ 32.72万 - 项目类别:
CD8 T cell antigen recognition during chronic infection
慢性感染期间CD8 T细胞抗原识别
- 批准号:
10356105 - 财政年份:2020
- 资助金额:
$ 32.72万 - 项目类别:
CD8 T cell antigen recognition during chronic infection
慢性感染期间CD8 T细胞抗原识别
- 批准号:
10582733 - 财政年份:2020
- 资助金额:
$ 32.72万 - 项目类别:
Cross-disciplinary Training in Immunology, Inflammation and Infectious Disease
免疫学、炎症和传染病的跨学科培训
- 批准号:
10413164 - 财政年份:2018
- 资助金额:
$ 32.72万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 32.72万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 32.72万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 32.72万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 32.72万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 32.72万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 32.72万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 32.72万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 32.72万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 32.72万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 32.72万 - 项目类别:
Research Grant